ArticleBMC surgery2025
The impact of flap dehiscence on the long-term speech outcome of furlow palatoplasty.
Article in BMC surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundFlap dehiscence is a common complication observed after Furlow palatoplasty, but its impact on speech outcome is unclear. This study aimed to test the hypothesis that flap dehiscence following Furlow palatoplasty significantly increases the risk of adverse long-term speech outcomes.
methodsThis retrospective cohort study reviewed patients with soft cleft palate (SCP), submucous cleft palate (SMCP), or secondary velopharyngeal incompetence (VPI) who underwent Furlow palatoplasty from 2013 to 2023 at a tertiary hospital-based cleft center. The exposure variable was wound healing status, categorized as primary healing (without flap dehiscence), secondary healing (with flap dehiscence), or persistent fistulae formation. The location, size, and healing duration of flap dehiscence were also documented. The primary outcome was postoperative velopharyngeal function, assessed through standardized speech evaluations. Associations were analyzed using univariate and multivariate logistic regression models.
resultsA total of 431 patients receiving Furlow palatoplasty were enrolled, with 12.5% reported flap dehiscence and 3.0% with persistent oronasal fistulae. For both primary cleft repair and secondary VPI correction, the occurrence of flap dehiscence and age at operation were identified as in significant correlation with postoperative velopharyngeal function. Patients with secondary healing demonstrated a higher rate of hypernasality and worse speech intelligibility. In addition, those with dehiscence size larger than 1cm
conclusionFlap dehiscence is a significant prognostic factor in long-term speech outcomes following Furlow palatoplasty. Wound healing monitor is necessary for the comprehensive evaluation of cleft repair techniques.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.